Shuang Ye

Department of Rheumatology, Shanghai Jiaotong University

Affiliated withShanghai Jiaotong University Dalian Third People's Hospital Affiliated to Dalian University of Technology

Research Area

Medicine

Biography

Shuang Ye has not added Biography.
If you are Shuang Ye and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 2	2025
$Arthroscopic Guided Synovectomy, Synovial Biopsies, and Pathotype Identification in Refractory Rheumatoid Arthritis$ Publication title	2025
Publication title	2026

Other Publications

Article	Year
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial. RMD open\| PubMed ID: 36288823	2022
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clinical reviews in allergy & immunology\| PubMed ID: 33405101	2021
tRNA derived fragment (tRF)-3009 participates in modulation of IFN-α-induced CD4 T cell oxidative phosphorylation in lupus patients. Journal of translational medicine\| PubMed ID: 34256772	2021
A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Scientific reports\| PubMed ID: 34426622	2021
Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis. Clinical and experimental rheumatology\| PubMed ID: 34874833	2022
Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lupus science & medicine\| PubMed ID: 35105722	2022
Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity. Lupus science & medicine\| PubMed ID: 35606018	2022
Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection. The Lancet. Infectious diseases\| PubMed ID: 35843259	2022
Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study. Lupus science & medicine\| PubMed ID: 36041813	2022
Pneumomediastinum and Subcutaneous Facial Emphysema in Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis. The Journal of rheumatology\| PubMed ID: 36109072	2023
Analysis of microRNA-199a-3p expression in CD4 T cells of systemic lupus erythematosus. Clinical rheumatology\| PubMed ID: 36763225	2023
Four trajectories of 24-hour urine protein levels in real-world lupus nephritis cohorts. RMD open\| PubMed ID: 37208030	2023
[Ga]Ga-FAPI-04 and [F]FDG PET/ CT in a patient with MDA5 dermatomyositis. European journal of nuclear medicine and molecular imaging\| PubMed ID: 37272957	2023
Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody. RMD open\| PubMed ID: 38199847	2024
PD-1/PD-L1 governed cross-talk of exhausted CD8 T and memory B cells in systemic lupus erythematosus. RMD open\| PubMed ID: 38233074	2024
A molecular signature as a guidance for glucocorticoid: are we there yet? The Lancet. Rheumatology\| PubMed ID: 38279388	2021
Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis. Lupus science & medicine\| PubMed ID: 38806217	2024
Effectiveness and safety of tofacitinib calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study. The European respiratory journal\| PubMed ID: 39884766	2025
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study. Seminars in arthritis and rheumatism\| PubMed ID: 40122014	2025
Reply: Tofacitinib is a step forward for management of patients with interstitial lung disease associated with anti-MDA5-positive dermatomyositis. The European respiratory journal\| PubMed ID: 40659470	2025
Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus. Clinical rheumatology\| PubMed ID: 17021668	2007
Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis and rheumatism\| PubMed ID: 18311820	2008
Central nervous system infections in the systemic vasculitides. Current opinion in neurology\| PubMed ID: 18451720	2008
Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis. PloS one\| PubMed ID: 20559547	2010
Rituximab in the treatment of severe lupus myelopathy. Clinical rheumatology\| PubMed ID: 21340494	2011
Severe systemic lupus erythematosus in emergency department: a retrospective single-center study from China. Clinical rheumatology\| PubMed ID: 21842147	2011
Invasive fungal infection in Chinese patients with systemic lupus erythematosus. Clinical rheumatology\| PubMed ID: 22476206	2012
FTY720 attenuates paraquat-induced lung injury in mice. International immunopharmacology\| PubMed ID: 24893116	2014
Severe pulmonary arterial hypertension secondary to lupus in the emergency department: proactive intense care associated with a better short-term survival. International journal of rheumatic diseases\| PubMed ID: 24946184	2015
SirT1 knockdown potentiates radiation-induced bystander effect through promoting c-Myc activity and thus facilitating ROS accumulation. Mutation research\| PubMed ID: 25772107	2015
Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Arthritis & rheumatology (Hoboken, N.J.)\| PubMed ID: 26245802	2015
Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis. Scientific reports\| PubMed ID: 27615411	2016
Reply. Arthritis & rheumatology (Hoboken, N.J.)\| PubMed ID: 27636588	2016
Protective effect of mild endoplasmic reticulum stress on radiation-induced bystander effects in hepatocyte cells. Scientific reports\| PubMed ID: 27958308	2016
Clinical patterns and characteristics of ankylosing spondylitis in China. Clinical rheumatology\| PubMed ID: 28550390	2017
Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China. Patient preference and adherence\| PubMed ID: 29075106	2017
Primary Hypertrophic Osteoarthropathy With SLCO2A1 Mutation in a Chinese Patient Successfully Treated With Etoricoxib. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\| PubMed ID: 29239930	2018
Tocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases\| PubMed ID: 29389687	2019
Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis. Clinical rheumatology\| PubMed ID: 29589132	2018
Two distinct clinical phenotypes of pulmonary arterial hypertension secondary to systemic lupus erythematosus. Annals of the rheumatic diseases\| PubMed ID: 30232194	2019
Response to: 'Inflammation in SLE-PAH: good news or not?' by Junyan Qian . Annals of the rheumatic diseases\| PubMed ID: 30429119	2019
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease. Rheumatology (Oxford, England)\| PubMed ID: 30508148	2019
NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker. Journal of translational medicine\| PubMed ID: 30577810	2018
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease. Rheumatology (Oxford, England)\| PubMed ID: 30590756	2019
A multidisciplinary clinic approach to improve physician-related diagnostic delay for patients with axial spondyloarthritis: a retrospective study. The Journal of international medical research\| PubMed ID: 31020890	2019
Varicella zoster virus infections increase the risk of disease flares in patients with SLE: a matched cohort study. Lupus science & medicine\| PubMed ID: 31413853	2019
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE. International immunopharmacology\| PubMed ID: 31499270	2019
Systemic lupus erythematosus gastrointestinal involvement: a computed tomography-based assessment. Scientific reports\| PubMed ID: 32286471	2020
Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study. Clinical rheumatology\| PubMed ID: 32418039	2020
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials. Lupus science & medicine\| PubMed ID: 33093216	2020
The gut microbiota of non-treated patients with SLE defines an autoimmunogenic and proinflammatory profile. Arthritis & rheumatology (Hoboken, N.J.)\| PubMed ID: 33124780	2020
Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. Journal of inflammation research\| PubMed ID: 33376379	2020
D-mannose ameliorates autoimmune phenotypes in mouse models of lupus. BMC immunology\| PubMed ID: 33402096	2021
The role of pirfenidone in the treatment of interstitial pneumonia with autoimmune features. Clinical and experimental rheumatology\| PubMed ID: 33822701	2022
Epidemiology of Takayasu arteritis in Shanghai: A hospital-based study and systematic review. International journal of rheumatic diseases\| PubMed ID: 34314100	2021
Description and Analysis of a Novel Subtype of the Anti-Synthetase Syndrome Characterized by Frequent Attacks of Fever and Systemic Inflammation in a Single-Center Cohort Study. Frontiers in immunology\| PubMed ID: 34630407	2021
One-year renal outcome in lupus nephritis patients with acute kidney injury: a nomogram model. Rheumatology (Oxford, England)\| PubMed ID: 34726692	2022
Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Intersti... Frontiers in medicine\| PubMed ID: 35111785	2021
Spontaneous Intramuscular Hemorrhage in Anti-MDA5 Positive Dermatomyositis: A Case Series and Literature Review. Frontiers in medicine\| PubMed ID: 35141250	2021
Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome. Clinical rheumatology\| PubMed ID: 35590113	2022
Inflammation, new bone formation and aorta. International journal of rheumatic diseases\| PubMed ID: 35694775	2022
Editorial: Anti-MDA5-Positive Dermatomyositis. Frontiers in medicine\| PubMed ID: 35712109	2022
Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease. Arthritis & rheumatology (Hoboken, N.J.)\| PubMed ID: 35713981	2022
Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease. Rheumatology (Oxford, England)\| PubMed ID: 36130290	2023
CIDP-like autoimmune nodopathy complicated with focal segmental glomerulosclerosis: a case study and literature review. Journal of neurology\| PubMed ID: 36178542	2023
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications. Nature communications\| PubMed ID: 36309526	2022
Ruxolitinib rescued the macrophage activation syndrome in adult-onset Still's disease with delayed hypersensitivity reaction to tocilizumab. Rheumatology (Oxford, England)\| PubMed ID: 36519834	2023
WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease. Rheumatology (Oxford, England)\| PubMed ID: 36637178	2023
Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study. Biomedicines\| PubMed ID: 36979944	2023
The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis. Clinical rheumatology\| PubMed ID: 37415053	2023
Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis. Clinical rheumatology\| PubMed ID: 37556006	2023
Intention to treat: The management of connective tissue disease-related immune thrombocytopenia. International journal of rheumatic diseases\| PubMed ID: 37807615	2023
Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. Rheumatology\| PubMed ID: 38268156	2020
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database. Annals of the rheumatic diseases\| PubMed ID: 39894689	2025
Case Report: Spesolimab for pyoderma gangrenosum in an undifferentiated oligoarthritis patient receiving anti-IL-17 therapy. Frontiers in immunology\| PubMed ID: 40260260	2025
The changes in global burden of autoimmune diseases two years after the COVID-19 pandemic: a trend analysis based on the Global Burden of Disease Study 2021. Journal of translational autoimmunity\| PubMed ID: 40342869	2025
Calibrating Anti-Double-Stranded DNA Antibodies Detections Using Likelihood Ratios. International journal of rheumatic diseases\| PubMed ID: 40599103	2025
Producing an Anti-dsDNA Antibody Reference Reagents to Calibrate Different Quantitative Assays in China. International journal of rheumatic diseases\| PubMed ID: 40631518	2025
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus. Annals of the rheumatic diseases\| PubMed ID: 40858468	2025
Efficacy of JAK inhibitor combined with protein A immunoadsorption in MDA5+ dermatomyositis with RPILD: A real-world study. Med (New York, N.Y.)\| PubMed ID: 40925379	2025
Spontaneous pneumomediastinum and/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system. Respiratory research\| PubMed ID: 41034976	2025